Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1185-1191

  Hattangadi Gluth, Jona A ^a   Wo, Jennifer Y ^b   Nguyen, Paul L ^c   Abi Raad, Rita F ^b   Sreedhara, Meera ^c   Niemierko, Andrzej ^b   Freer, Phoebe E ^b   Georgian Smith, Dianne ^c   Bellon, Jennifer R ^c   Wong, Julia S ^c   Smith, Barbara L ^b   Harris, Jay R ^c   Taghian, Alphonse G ^b  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Basal; Biologic subtype; Breast cancer; Elsewhere local recurrence; Local recurrence; Triple negative; True recurrence

Indexed keywords

BASAL; BIOLOGIC SUBTYPE; BREAST CANCER; LOCAL RECURRENCE; TRIPLE NEGATIVE; TRUE RECURRENCE;

CHEMOTHERAPY; DISEASES; MONOCLONAL ANTIBODIES; MULTIVARIANT ANALYSIS; RADIOTHERAPY; TUMORS;

MEDICAL IMAGING;

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BASAL CELL CARCINOMA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; ELSEWHERE LOCAL RECURRENCE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INVASIVE BREAST CANCER; IPSILATERAL BREAST TUMOR RECURRENCE; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PHYSICIAN; PRIORITY JOURNAL; RADIOLOGIST; RECURRENCE RISK; TRUE RECURRENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK; TUMOR BURDEN; YOUNG ADULT;

EID: 84856373144     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.02.061     Document Type: Article

References (43)

1. B. Fisher, S. Anderson, and J. Bryant Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 2002 1233 1241
2. J.A. Jacobson, D.N. Danforth, and K.H. Cowan Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer N Engl J Med 332 1995 907 911
3. U. Veronesi, N. Cascinelli, and L. Mariani Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 347 2002 1227 1232
4. G.M. Freedman, P.R. Anderson, and A.L. Hanlon Pattern of local recurrence after conservative surgery and whole-breast irradiation Int J Radiat Oncol Biol Phys 61 2005 1328 1336
5. B. Fisher, J. Bryant, and J.J. Dignam Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less J Clin Oncol 20 2002 4141 4149
6. S.J. Anderson, I. Wapnir, and J.J. Dignam Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer J Clin Oncol 27 2009 2466 2473
7. U. Veronesi, E. Marubini, and M. Del Vecchio Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events J Natl Cancer Inst 87 1995 19 27
8. S.J. Schnitt, J. Hayman, and R. Gelman A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer Cancer 77 1996 1094 1100
9. U. Veronesi, E. Marubini, and L. Mariani Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial Ann Oncol 12 2001 997 1003
10. B. Fowble, L.J. Solin, and D.J. Schultz Breast recurrence following conservative surgery and radiation: Patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment Int J Radiat Oncol Biol Phys 19 1990 833 842
11. D.M. Gujral, G. Sumo, and J.R. Owen Ipsilateral breast tumor relapse: Local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries Int J Radiat Oncol Biol Phys 79 2011 19 25
12. E. Huang, T.A. Buchholz, and F. Meric Classifying local disease recurrences after breast conservation therapy based on location and histology: New primary tumors have more favorable outcomes than true local disease recurrences Cancer 95 2002 2059 2067
13. Y. Komoike, F. Akiyama, and Y. Iino Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors Breast Cancer 12 2005 104 111
14. T.E. Smith, D. Lee, and B.C. Turner True recurrence versus new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management Int J Radiat Oncol Biol Phys 48 2000 1281 1289
15. A. Recht, W. Silen, and S.J. Schnitt Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer Int J Radiat Oncol Biol Phys 15 1988 255 261
16. J.M. Kurtz, R. Amalric, and H. Brandone Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis Cancer 63 1989 1912 1917
17. B.D. Smith, D.W. Arthur, and T.A. Buchholz Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO) Int J Radiat Oncol Biol Phys 74 2009 987 1001
18. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
19. T. Sorlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869 10874
20. J.D. Brenton, L.A. Carey, and A.A. Ahmed Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? J Clin Oncol 23 2005 7350 7360
21. J.M. Albert, A.M. Gonzalez-Angulo, and M. Guray Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer Int J Radiat Oncol Biol Phys 77 2010 1296 1302
22. P.L. Nguyen, A.G. Taghian, and M.S. Katz Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 2008 2373 2378
23. J.Y. Wo, A.G. Taghian, and P.L. Nguyen The association between biological subtype and isolated regional nodal failure after breast-conserving therapy Int J Radiat Oncol Biol Phys 77 2010 188 196
24. K.D. Voduc, M.C. Cheang, and S. Tyldesley Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 2010 1684 1691
25. E.K. Millar, P.H. Graham, and S.A. O'Toole Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel J Clin Oncol 27 2009 4701 4708
26. M. Kyndi, F.B. Sorensen, and H. Knudsen Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group J Clin Oncol 26 2008 1419 1426
27. F.L.P.D. Greene, D.L. Page, and I.D. Fleming AJCC cancer staging manual 6th ed. 2002 Springer New York
28. M.J. Piccart-Gebhart, M. Procter, and B. Leyland-Jones Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 2005 1659 1672
29. L.A. Carey, C.M. Perou, and C.A. Livasy Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492 2502
30. I. Gage, A. Recht, and R. Gelman Long-term outcome following breast-conserving surgery and radiation therapy Int J Radiat Oncol Biol Phys 33 1995 245 251
31. R.R. Parikh, D. Housman, and Q. Yang Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer Int J Radiat Oncol Biol Phys 72 2008 1056 1063
32. A. Recht, B. Silver, and S. Schnitt Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage Int J Radiat Oncol Biol Phys 11 1985 1271 1276
33. S. Banerjee, J.S. Reis-Filho, and S. Ashley Basal-like breast carcinomas: Clinical outcome and response to chemotherapy J Clin Pathol 59 2006 729 735
34. S.J. Dawson, E. Provenzano, and C. Caldas Triple negative breast cancers: Clinical and prognostic implications Eur J Cancer 45 Suppl 1 2009 27 40
35. O. Gluz, C. Liedtke, and N. Gottschalk Triple-negative breast cancer - Current status and future directions Ann Oncol 20 2009 1913 1927
36. M. Robson, T. Gilewski, and B. Haas BRCA-associated breast cancer in young women J Clin Oncol 16 1998 1642 1649
37. B.G. Haffty, E. Harrold, and A.J. Khan Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Lancet 359 2002 1471 1477
38. H. Bartelink, J.C. Horiot, and P.M. Poortmans Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 2007 3259 3265
39. J.J. Jobsen, J. van der Palen, and F. Ong The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only Int J Radiat Oncol Biol Phys 57 2003 724 731
40. A.C. Voogd, M. Nielsen, and J.L. Peterse Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials J Clin Oncol 19 2001 1688 1697
41. P. Zhou, and A. Recht Young age and outcome for women with early-stage invasive breast carcinoma Cancer 101 2004 1264 1274
42. E.H. Romond, E.A. Perez, and J. Bryant Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 2005 1673 1684
43. B.L. Schlechter, Q. Yang, and P.S. Larson Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence J Clin Oncol 22 2004 1830 1838